On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Additional Analysis Deems Irritable Bowel Syndrome Drug Rifaximin Safe
April 22nd 2014Rifaximin, an antibiotic intended to treat non-constipation-predominant irritable bowel syndrome (non-C IBS), was deemed safe in an analysis published online in the May issue of Alimentary Pharmacology & Therapeutics.
Prophylactic Anticoagulation Preferred Over Mechanical Devices
Prophylactic anticoagulation results in a lower risk of dying among patients in the intensive care unit compared with the use of mechanical devices for protection against venous thromboembolism, according to new research.
States' Rights, Zohydro, and Pain Management
April 21st 2014Following the approval of Zohydro last year, attorneys general across the country requested the FDA reconsider its decision until the medication could be reformulated to include abuse-deterrent properties. Now, two states have moved to reduce access to Zohydro. Will the courts uphold these decisions, or will other states follow in their wake?
Controversy Over Childhood Obesity Statistics
April 21st 2014Researchers from the University of North Carolina School of Medicine are contesting a February 2014 Centers for Disease Control and Prevention report that indicated childhood obesity is stabilizing and has dropped 43% among 2- to 5-year-olds.